annual CFF:
-$337.50M-$170.10M(-101.62%)Summary
- As of today (May 24, 2025), GDRX annual cash flow from financing activities is -$337.50 million, with the most recent change of -$170.10 million (-101.62%) on December 31, 2024.
- During the last 3 years, GDRX annual CFF has fallen by -$306.97 million (-1005.53%).
- GDRX annual CFF is now -137.26% below its all-time high of $905.82 million, reached on December 31, 2020.
Performance
GDRX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$104.90M-$101.37M(-2871.73%)Summary
- As of today (May 24, 2025), GDRX quarterly cash flow from financing activities is -$104.90 million, with the most recent change of -$101.37 million (-2871.73%) on March 31, 2025.
- Over the past year, GDRX quarterly CFF has increased by +$56.07 million (+34.83%).
- GDRX quarterly CFF is now -110.57% below its all-time high of $992.12 million, reached on September 30, 2020.
Performance
GDRX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$281.43M+$56.07M(+16.61%)Summary
- As of today (May 24, 2025), GDRX TTM cash flow from financing activities is -$281.43 million, with the most recent change of +$56.07 million (+16.61%) on March 31, 2025.
- Over the past year, GDRX TTM CFF has increased by +$32.85 million (+10.45%).
- GDRX TTM CFF is now -127.67% below its all-time high of $1.02 billion, reached on September 30, 2020.
Performance
GDRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GDRX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.6% | +34.8% | +10.4% |
| 3 y3 years | -1005.5% | -14.8% | -160.8% |
| 5 y5 years | -516.1% | -480.1% | -1119.6% |
GDRX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1005.5% | at low | <-9999.0% | +39.1% | -555.8% | +38.8% |
| 5 y | 5-year | -137.3% | at low | -110.6% | +39.1% | -127.7% | +38.8% |
| alltime | all time | -137.3% | at low | -110.6% | +39.1% | -127.7% | +38.8% |
GDRX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$104.90M(+2871.7%) | -$281.43M(-16.6%) |
| Dec 2024 | -$337.50M(+101.6%) | -$3.53M(-97.9%) | -$337.50M(-26.6%) |
| Sep 2024 | - | -$172.13M(>+9900.0%) | -$459.57M(+52.6%) |
| Jun 2024 | - | -$864.00K(-99.5%) | -$301.15M(-4.2%) |
| Mar 2024 | - | -$160.97M(+28.2%) | -$314.28M(+87.7%) |
| Dec 2023 | -$167.40M(+39.2%) | -$125.61M(+816.4%) | -$167.40M(+259.4%) |
| Sep 2023 | - | -$13.71M(-2.1%) | -$46.58M(-14.7%) |
| Jun 2023 | - | -$13.99M(-0.7%) | -$54.58M(+27.2%) |
| Mar 2023 | - | -$14.09M(+194.4%) | -$42.91M(-64.3%) |
| Dec 2022 | -$120.23M | -$4.79M(-78.0%) | -$120.23M(-5.3%) |
| Sep 2022 | - | -$21.71M(+832.6%) | -$126.91M(+16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$2.33M(-97.5%) | -$109.37M(+1.4%) |
| Mar 2022 | - | -$91.40M(+697.2%) | -$107.91M(+253.5%) |
| Dec 2021 | -$30.53M(-103.4%) | -$11.46M(+174.3%) | -$30.53M(-76.6%) |
| Sep 2021 | - | -$4.18M(+383.2%) | -$130.44M(-115.1%) |
| Jun 2021 | - | -$865.00K(-93.8%) | $865.87M(+0.2%) |
| Mar 2021 | - | -$14.02M(-87.4%) | $864.20M(-4.6%) |
| Dec 2020 | $905.82M(-1753.5%) | -$111.37M(-111.2%) | $905.82M(-10.9%) |
| Sep 2020 | - | $992.12M(<-9900.0%) | $1.02B(+3957.6%) |
| Jun 2020 | - | -$2.53M(-109.2%) | $25.07M(-9.2%) |
| Mar 2020 | - | $27.60M | $27.60M |
| Dec 2019 | -$54.78M(+121.5%) | - | - |
| Dec 2018 | -$24.73M | - | - |
FAQ
- What is GoodRx Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GoodRx Holdings?
- What is GoodRx Holdings annual CFF year-on-year change?
- What is GoodRx Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GoodRx Holdings?
- What is GoodRx Holdings quarterly CFF year-on-year change?
- What is GoodRx Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GoodRx Holdings?
- What is GoodRx Holdings TTM CFF year-on-year change?
What is GoodRx Holdings annual cash flow from financing activities?
The current annual CFF of GDRX is -$337.50M
What is the all time high annual CFF for GoodRx Holdings?
GoodRx Holdings all-time high annual cash flow from financing activities is $905.82M
What is GoodRx Holdings annual CFF year-on-year change?
Over the past year, GDRX annual cash flow from financing activities has changed by -$170.10M (-101.62%)
What is GoodRx Holdings quarterly cash flow from financing activities?
The current quarterly CFF of GDRX is -$104.90M
What is the all time high quarterly CFF for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash flow from financing activities is $992.12M
What is GoodRx Holdings quarterly CFF year-on-year change?
Over the past year, GDRX quarterly cash flow from financing activities has changed by +$56.07M (+34.83%)
What is GoodRx Holdings TTM cash flow from financing activities?
The current TTM CFF of GDRX is -$281.43M
What is the all time high TTM CFF for GoodRx Holdings?
GoodRx Holdings all-time high TTM cash flow from financing activities is $1.02B
What is GoodRx Holdings TTM CFF year-on-year change?
Over the past year, GDRX TTM cash flow from financing activities has changed by +$32.85M (+10.45%)